Exploration of Drug Science

AUG 17, 2026 · JOURNAL ARTICLE

Synchronizing obesity management with survodutide

Exploration of Drug Science

Phase 3 RCT with sustained, clinically meaningful weight loss and metabolic improvements over 76 weeks, but lacks active comparator and cardiovascular outcomes needed for practice-changing status.

AUG 17, 2026 · JOURNAL ARTICLE

Synergistic attack of “old drugs for new uses”: repositioning strategies in cancer combination therapy

Exploration of Drug Science

This is a narrative review article that synthesizes existing evidence on drug repositioning concepts and mechanisms rather than reporting original empirical findings or clinical outcomes from a controlled study.